High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain
- PMID: 33988951
High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain
Abstract
Background: Associations between attention-deficit/hyperactivity disorder (ADHD) and chronic pain disorders, such as fibromyalgia, have been reported. However, associations between persistent chronic nonspecific low back pain (CNLBP) and ADHD have not yet been investigated.
Objectives: This study aimed to investigate the positive rates of possible ADHD, as assessed by self-reported ADHD scales, in patients with persistent CNLBP, using data from self-reported questionnaires completed by patients and their families. This study also aimed to compare the self-reported scores obtained from existing standardized data for healthy individuals, and to examine whether the ADHD scale scores of patients with persistent CNLBP are associated with pain variables.
Study design: Cross-sectional study.
Setting: The specialized pain clinic at our university hospital.
Methods: This cross-sectional study included 60 consecutive patients with persistent CNLBP who were diagnosed with a possible somatic symptom disorder and were referred to a psychiatrist in our pain clinic. The Conners' Adult ADHD Rating Scales (CAARS) self-report (CAARS-S) and observer-rated (CAARS-O) questionnaires were utilized. We investigated the CAARS scores, and the association between the CAARS subscale scores and pain variables (pain duration and pain Numeric Rating Scale) in patients with persistent CNLBP.
Results: Of the 60 patients, 19 (31.7%) were positive on both CAARS-S and CAARS-O questionnaires (T-score > 65). The ADHD indices, which comprised subscales of the CAARS estimating the necessity of treatment for ADHD, were significantly higher in both male and female patients with persistent CNLBP than in the Japanese standardized sample (P < 0.005). CAARS-S hyperactivity/restlessness, CAARS-O hyperactivity/restlessness, and the Diagnostic and Statistical Manual of Mental Disorders, fourth edition hyperactive-impulsive symptom subscale scores also correlated with the pain intensity (P < 0.05).
Limitations: In this study, ADHD tendency was evaluated using only a self-reported questionnaire. Hence in the future, accurate and precise assessments of ADHD symptoms using structured clinical interviews conducted by ADHD experts are warranted. Additionally, the study only included patients with persistent CNLBP. Therefore in the future, it will be valuable to investigate ADHD scale scores (e.g., CAARS) among patients with CNLBP and nonspecific low back pain with larger sample sizes.
Conclusions: Our findings revealed that the subscale scores on an ADHD scale were considerably high in patients with persistent CNLBP. As a previous study of our clinical experience indicates that persistent CNLBP can be substantially relieved by administering ADHD medications, ADHD screening is warranted in the treatment of persistent CNLBP.
Keywords: Conners’ Adult ADHD Rating Scales (CAARS); Numeric Rating Scale; chronic nonspecific low back pain; chronic pain; neurodevelopmental disorders; pain clinic; pain duration; somatic symptom disorder; Attention-deficit/hyperactivity disorder.
Similar articles
-
Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.CNS Drugs. 2016 Jun;30(6):541-58. doi: 10.1007/s40263-016-0346-3. CNS Drugs. 2016. PMID: 27224994
-
German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensitivity and specificity.Eur Psychiatry. 2012 Jul;27(5):321-8. doi: 10.1016/j.eurpsy.2010.12.010. Epub 2011 Mar 9. Eur Psychiatry. 2012. PMID: 21392946
-
Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate.Psychol Med. 2012 Jan;42(1):195-204. doi: 10.1017/S0033291711000845. Epub 2011 Jun 1. Psychol Med. 2012. PMID: 21733214 Free PMC article. Clinical Trial.
-
Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256 Suppl 1:i3-11. doi: 10.1007/s00406-006-1001-7. Eur Arch Psychiatry Clin Neurosci. 2006. PMID: 16977549 Review.
-
Evaluating the Psychometric Properties of the Conners Adult ADHD Rating Scales.J Atten Disord. 2019 Aug;23(10):1111-1118. doi: 10.1177/1087054715624230. Epub 2016 Feb 2. J Atten Disord. 2019. PMID: 26838556 Review.
Cited by
-
Persistence of Low Back Pain and Predictive Ability of Pain Intensity and Disability in Daily Life among Nursery School Workers in Japan: A Five-Year Panel Study.Healthcare (Basel). 2024 Jan 5;12(2):128. doi: 10.3390/healthcare12020128. Healthcare (Basel). 2024. PMID: 38255017 Free PMC article.
-
Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder.Front Pediatr. 2023 Nov 1;11:1283823. doi: 10.3389/fped.2023.1283823. eCollection 2023. Front Pediatr. 2023. PMID: 38027301 Free PMC article.
-
Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder.Front Psychiatry. 2023 Aug 7;14:1221694. doi: 10.3389/fpsyt.2023.1221694. eCollection 2023. Front Psychiatry. 2023. PMID: 37608999 Free PMC article.
-
Improvement in persistent idiopathic facial pain with comorbid ADHD using the combination of a dopamine system stabilizer and psychostimulant: A case report.Clin Case Rep. 2023 Jun 19;11(6):e7552. doi: 10.1002/ccr3.7552. eCollection 2023 Jun. Clin Case Rep. 2023. PMID: 37346882 Free PMC article.
-
Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole.Front Pain Res (Lausanne). 2023 Jun 5;4:1159134. doi: 10.3389/fpain.2023.1159134. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37342213 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials